Amanta Healthcare Limited – IPO
Amanta Healthcare Limited – IPO Details
| IPO Date | September 1, 2025 to September 3, 2025 |
| Listing Date | September 9, 2025 |
| Face Value | ₹ 10 / Share |
| Price Band | ₹ 120 to ₹ 126 / Share |
| Lot Size | 119 Shares |
| Total Issue Size | 1,00,00,000 shares (Aggregating up to ₹126.00 Cr) |
| Fresh Issue | |
| Offer for Sale | |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 2,88,29,351 shares |
| Share holding post issue | 3,88,29,351 shares |
| Market Maker portion |
Amanta Healthcare Limited Timeline (Tentative Schedule)
Amanta Healthcare Limited IPO opens on September 1, 2025, and closes on September 3, 2025.
| IPO Open Date | September 1, 2025 |
| IPO Close Date | September 3, 2025 |
| Basis of Allotment | September 4, 2025 |
| Initiation of Refunds | September 8, 2025 |
| Credit of Shares to Demat | September 8, 2025 |
| Listing Date | September 9, 2025 |
| Cut-off time for UPI mandate confirmation | September 3, 2025 |
Amanta Healthcare Limited IPO Lot Size
Investors can bid for a minimum of 119 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 119 | Rs.14,994 |
| Retail (Max) | 13 | 1,547 | Rs.194,922 |
| S-HNI (Min) | 14 | 1,666 | Rs.209,916 |
| S-HNI (Max) | 66 | 7,854 | Rs.989,604 |
| B-HNI (Min) | 67 | 7,973 | Rs.1,004,598 |
| HNI (Min) |
Amanta Healthcare Limited IPO Promoter Holding
| Share Holding Pre Issue | 85.60% |
| Share Holding Post Issue | 63.56% |
Amanta Healthcare Limited IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | |
|
| Other Shares Offered | |
|
| QIB Shares Offered | Not more than 50.00% |
|
| NII (HNI) Shares Offered | Not less than 15.00% |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | Not less than 35.00% |
|
| Employee Shares Offered | |
|
| Total Shares Offered | |
Amanta Healthcare Limited IPO Anchor Investors Details
| Bid Date | |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | |
| Anchor lock-in period end date for 50% shares (30 Days) | |
| Anchor lock-in period end date for remaining shares (90 Days) |
About Amanta Healthcare Limited
Founded in December 1994, Amanta Healthcare Limited is a pharmaceutical firm engaged in the production, development, and marketing of a wide range of sterile liquid products, more particularly parenteral products, in plastic containers using Aseptic Blow-Fill-Seal ("ABFS") and Injection Stretch Blow Moulding ("ISBM") technology. It also operates as a manufacturer of medical devices.
The firm produces fluid therapy preparation products, such as IV products, diluents, ophthalmic solutions, and respiratory care solutions. It also sells irrigation solutions, first-aid products, and eye lubricants under the medical device segment.
The firm sells products through three business segments:
National sales,
International sales and
Product partnerships with different foreign and Indian pharmaceutical firms.
The firm produces more than 45 generic products, selling them under their own brands in India through 320 stockists and distributors.
The company markets products in Africa, Latin America, the UK, and internationally. The company's products are registered in 19 nations and are in accordance with several regulations. During Fiscal 2025, the company shipped branded products to 21 countries.
As of March 31, 2025, the company has 1,718 employees in its formulation and development and quality laboratory.
Competitive Strengths
Established pharmaceutical formulation manufacturer with diversified product line and diversified market.
Spacious manufacturing facilities
Extensive Domestic and International Marketing Network.
Well-established management with a strong support base provided by a large, diversified and skilled workforce.
Key Performance Indicator
The market capitalization of the Amanta Healthcare IPO is ₹489.25 Cr.
| KPI | Values |
|---|---|
| ROE | 12.42% |
| ROCE | 13.72% |
| Debt/Equity | 2.02 |
| RoNW | 10.89% |
| P/BV | 3.77 |
| PAT Margin (%) | 3.86% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 3.64 | 2.70 |
| P/E (x) | 34.59 | 46.59 |
Note:
- The Pre IPO EPS is calculated based on Pre issue shareholding as on the date of RHP and the latest FY earnings as of March 31, 2025, that is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of March 31, 2025, which is available in RHP.
Objects of the Issue (Amanta Healthcare Limited IPO Objectives)
Amanta Healthcare Limited Contact Details
Amanta Healthcare Ltd. 8th Floor, Shaligram Corporates C.J. Marg Ambli, Ahmedabad, Gujarat, 380058 Phone: 079 67777600 Email: [email protected] Website: https://www.amanta.co.in/ |
Amanta Healthcare Limited IPO Registrar
MUFG Intime India Pvt.Ltd. Phone: +91-22-4918 6270 Email: [email protected] Website: https://linkintime.co.in/Initial_Offer/public-issues.html |